FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds
UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.
- 01UpDoc's diabetes management app receives FDA clearance.
- 02Aidoc achieves breakthrough device status for AI radiology reports.
- 03Regulatory milestones highlight AI's growing role in healthcare.
Jul 13, 2026